COMPASS Pathways PLC是一家总部位于英国的精神保健公司。该公司正在欧洲和北美通过后期临床试验为难治性抑郁症(TRD)患者开发裸盖菇素疗法。本公司已开发出 COMP360,这是一种裸盖菇素制剂,其中包含其药用级多晶型结晶裸盖菇素。该公司的 COMP360已在欧洲和北美的约22个地点完成了裸盖菇素治疗TRD的IIb期临床试验。其关于裸盖菇素治疗难治性抑郁症的随机对照IIb期研究是裸盖菇素治疗临床试验,在10个欧洲和北美国家的约22个地点参与了约233名患者。该试验评估了三种剂量的COMP360裸盖菇素治疗的安全性和有效性:1mg、10mg、25mg。该公司还在进行COMP360 psilocybin治疗创伤后应激障碍(PTSD)的II期临床试验。
名称 | 标题 | 任期 | 年龄 |
|---|---|---|---|
| Gino Santini | Independent Chairman | 2024 | 69 |
| Kabir Kumar Nath | CEO & Director | 2022 | 62 |
| Annalisa Lisa Mary Jenkins | Independent Non-Executive Director | 2018 | 61 |
| Daphne Karydas | Independent Director | 2023 | 53 |
| David York Norton | Independent Director | 2024 | 75 |
| Robert Dwyer McQuade | Independent Non Executive Director | 2020 | 69 |
| Wayne Joseph Riley | Independent Non-Executive Director | 2021 | 67 |
| Alan F. Schatzberg | Member of Scientific Advisory Network | - | 81 |
| Diego Pizzagalli | Member of Scientific Advisory Network | - | - |
| Gul Dolen | Member of Scientific Advisory Network | - | - |
| Kirk Rutter | Special Advisor of Patient Experience | - | - |
| John Rush | Member of Scientific Advisory Network | - | - |
| Paul Summergrad | Member of Scientific Advisory Network | - | - |
| Thomas R. Insel | Member of Scientific Advisory Network | - | 73 |
| Justin D. Gover | Independent Director | 2025 | 55 |
| Jeffrey M. Jonas | Independent Director | 2025 | 73 |